ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PNT POINT Biopharma Global Inc

12.50
0.00 (0.00%)
Apr 25 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
POINT Biopharma Global Inc PNT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 12.50 20:00:00
Open Price Low Price High Price Close Price Prev Close
12.50 12.50
more quote information »

Recent News

Date Time Source Heading
1/08/202407:00EDGAR2Form 15-12G - Securities registration termination [Section..
1/03/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
12/27/202317:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/27/202317:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/27/202317:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/27/202317:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/27/202317:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/27/202317:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/27/202317:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/27/202317:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/27/202309:44EDGAR2Form POS AM - Post-Effective amendments for registration..
12/27/202309:43EDGAR2Form POS AM - Post-Effective amendments for registration..
12/27/202309:42EDGAR2Form S-8 POS - Securities to be offered to employees in..
12/27/202308:54EDGAR2Form 8-K - Current report
12/27/202308:31PRNUSLilly Completes Acquisition of POINT Biopharma
12/18/202308:14EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
12/18/202307:30GLOBELantheus and POINT Biopharma Announce Positive Topline..
12/18/202306:45PRNUSLilly Extends Tender Offer to Acquire POINT Biopharma to..
12/05/202306:25IHMARKETNEWSMoody’s Reassesses China, GitLab Exceeds Estimates, Twilio..
12/04/202307:22EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
12/04/202306:45PRNUSLilly Extends Tender Offer to Acquire POINT Biopharma to..
11/17/202307:05EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
11/17/202306:45PRNUSLilly Extends Tender Offer to Acquire POINT Biopharma to..
11/15/202307:00EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
11/14/202316:33PRNUSLilly Announces the Receipt of NRC Consent in Connection..
11/13/202307:30GLOBEPOINT Biopharma Reports Third Quarter 2023 Financial Results..
11/13/202307:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202317:28EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
11/08/202316:56PRNUSLilly Announces Extension of Tender Offer to Acquire POINT..
11/07/202318:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/02/202318:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202316:40EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
10/27/202316:20EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
10/13/202307:11EDGAR2Form SC 14D9 - Solicitation, recommendation statements
10/03/202317:24EDGAR2Form SC14D9C - Written communication relating to third party..
10/03/202310:03IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Recommendations
10/03/202307:37EDGAR2Form SC14D9C - Written communication relating to third party..
10/03/202307:35EDGAR2Form 8-K - Current report
10/03/202306:45PRNUSLilly to Acquire POINT Biopharma to Expand Oncology..
9/18/202308:00GLOBEPOINT Biopharma and Athebio Announce Partnership to Develop..
8/14/202310:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
8/14/202307:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202307:30GLOBEPOINT Biopharma Reports Second Quarter 2023 Financial..
8/14/202307:21EDGAR2Form 8-K - Current report
8/03/202316:05EDGAR2Form 8-K - Current report
7/31/202309:00GLOBEITM and POINT Biopharma Expand Global Supply Agreement for..
6/26/202307:45GLOBEPOINT Biopharma and AdvanCell to Collaborate in the..
6/26/202307:30GLOBEPOINT Biopharma Expands Its Research with Next-Generation..
6/12/202308:00GLOBEPOINT Biopharma Announces Appointment of Dr. Bridget Martell..
6/07/202307:00GLOBEPOINT Biopharma to Host Virtual Investor Day on Tuesday,..

Your Recent History

Delayed Upgrade Clock